Leap Therapeutics, Inc.
LPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $47 | $71 | $21 | $115 |
| Short-Term Investments | $0 | $0 | $23 | $0 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $1 | $0 |
| Other Curr. Assets | $0 | $0 | $7 | $1 |
| Total Curr. Assets | $48 | $72 | $53 | $117 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $4 | $0 |
| Total NC Assets | $1 | $1 | $5 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $49 | $73 | $58 | $118 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $6 | $1 | $5 |
| Total Curr. Liab. | $14 | $13 | $3 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $0 |
| Total Liabilities | $14 | $13 | $3 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$467 | -$400 | -$106 | -$264 |
| AOCI | -$0 | $0 | $0 | -$0 |
| Other Equity | $503 | $460 | $160 | $372 |
| Total Equity | $35 | $60 | $55 | $108 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $49 | $73 | $58 | $118 |
| Net Debt | -$47 | -$70 | -$20 | -$114 |